TP53 and small cell lung carcinoma: Functionally inactivating RB1 and TP53 appeared to be enough to stimulate SCLC development in mice, whereas restoring their expression in human SCLC cell lines halted further tumorigenesis by the induction of G1-arrest and cell apoptosis (Fiorentino et al., 2016).